Nav: Home

Scripps first in West to treat heart attack with new supersaturated oxygen therapy

December 28, 2016

SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.

The recent treatments of two San Diego men were part of an ongoing clinical trial examining the effectiveness of the experimental SSO2 system and technique in combination with angioplasty, stenting and medication. Scripps is the only site in California participating in the nationwide study called IC-HOT (Evaluation of Intracoronary Hyperoxemic Oxygen Therapy).

"A heart attack is like a house fire, the longer it takes to put it out, the more structural damage that is done," said John C. Harrington, M.D., the interventional cardiologist who is leading the study at Scripps. "By infusing higher concentrations of oxygen into the artery responsible for the heart attack, we can decrease the size of the area of heart muscle that is damaged because it is deprived of oxygen."

Every year nearly 1 million people in the United States have a heart attack, typically caused when the blood flow carrying oxygen to the heart is reduced or blocked. Although the standard for heart attack care is angioplasty and stenting, for many patients those treatments aren't enough to salvage dead or damaged heart tissue that was starved of oxygen.

During SSO2 therapy developed by the Irvine, Calif., biotechnology company TherOx Inc., saline is drawn into a chamber in a disposable cartridge inserted into the treatment system. Supersaturated oxygen is sprayed into a second chamber and mixed with the saline. The patient's blood is circulated through a third chamber where it mixes with the SSO2 saline. The blood-oxygen-saline solution is then directed by catheter into the patient's coronary artery where it infuses the capillary bed and surrounding heart tissue. The procedure takes about one hour.

The IC-HOT study seeks to enroll 100 patients who suffer their first heart attack and receive SSO2 treatment within six hours of first experiencing symptoms. The study's primary aim is to validate the safety and effectiveness of the therapy system. Enrollment is expected to be completed by February 2017.

In a previous trial of an earlier generation of the TherOx system which didn't involve Scripps, heart attack patients experienced a median reduction of 26 percent in the size of the damaged area of their heart muscle tissue compared to angioplasty and stenting alone.

The treatment of heart attacks has advanced greatly over the past few decades, leading to improvements in mortality rates and decreased hospital stays. Minimally invasive catheter procedures, which deliver stents, angioplasty balloons and other treatments to the heart through veins and arteries, have greatly reduced the need for open heart surgeries.

Still, more needs to be done.

Patients with nearly identical characteristics - age, risk factors and cardiovascular muscle damage from the same type of heart attack -- can receive the same treatment but experience very different outcomes.

"One patient may have preserved heart function while the other may have a large area of heart tissue death," Dr. Harrington said. "Clearly there are additional factors that need to be explored to reduce heart muscle damage.

"The hope is that people receiving SSO2 treatment will leave the hospital with a less damaged heart," he said.
-end-
Scripps is the only heart care provider in the region consistently recognized by U.S. News & World Report as one of the best in the country. In 2016, U.S. News & World Report ranked Scripps 28th in the nation, the highest rated program in San Diego County.

ABOUT SCRIPPS HEALTH

Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a nonprofit integrated health care delivery system based in San Diego, Calif. Scripps treats more than 700,000 patients annually through the dedication of 3,000 affiliated physicians and more than 15,000 employees among its five acute-care hospital campuses, hospice and home health care services, 28 outpatient centers and clinics, and hundreds of affiliated physician offices throughout the region.

Recognized as a leader in disease and injury prevention, diagnosis and treatment, Scripps is also at the forefront of clinical research, genomic medicine and wireless health care. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges. Scripps has been ranked four times as one of the nation's best health care systems by Truven Health Analytics. Its hospitals are consistently ranked by U.S. News & World Report among the nation's best and Scripps is regularly recognized by Fortune, Working Mother magazine and AARP as one of the best places in the nation to work. More information can be found at http://www.scripps.org.

Scripps Health

Related Heart Attack Articles:

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.
New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.
Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.
A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.
Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.
Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.
Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.
How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.
Heart attack patients taken directly to heart centers have better long-term survival
Heart attack patients taken directly to heart centers for lifesaving treatment have better long-term survival than those transferred from another hospital, reports a large observational study presented today at Acute Cardiovascular Care 2019, a European Society of Cardiology congress.
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.
More Heart Attack News and Heart Attack Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.